Log in to save to my catalogue

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10101522

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

About this item

Full title

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Publisher

Korea (South): Korean Association for the Study of the Liver

Journal title

Clinical and Molecular Hepatology, 2023, 29(1), , pp.77-98

Language

English

Formats

Publication information

Publisher

Korea (South): Korean Association for the Study of the Liver

More information

Scope and Contents

Contents

The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepat...

Alternative Titles

Full title

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10101522

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10101522

Other Identifiers

ISSN

2287-2728

E-ISSN

2287-285X

DOI

10.3350/cmh.2022.0237

How to access this item